Replies to post #823449 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Thanks for posting this article from the Wall Street Journal. I especially like the part about how Vertex Pharmaceuticals built a dominant cystic-fibrosis franchise and became an acquirer in its own rights, and is now worth more than $100 billion:

Take Vertex Pharmaceuticals. Once a perennial takeover candidate, it built a dominant cystic-fibrosis franchise and became an acquirer in its own right, spreading its bets from gene editing to pain. It is now worth more than $100 billion. Regeneron, founded in 1988, spent decades as a speculative science project before massive blockbusters in ophthalmology and immunology turned it into a giant, now worth around $80 billion. The company’s scientist co-founders, Leonard Schleifer and George Yancopoulos, are still at the helm more than 35 years later.

I wonder how much a company would be worth, if it builds a dominant dendritic cell vaccine technology platform franchise that can treat all or most solid tumor cancers, both operable and inoperable?

My guess would be a lot more than $100 billion.